Frontiers in Molecular Biosciences (Oct 2022)

Semi-supervised segmentation of metastasis lesions in bone scan images

  • Qiang Lin,
  • Qiang Lin,
  • Qiang Lin,
  • Runxia Gao,
  • Runxia Gao,
  • Mingyang Luo,
  • Mingyang Luo,
  • Haijun Wang,
  • Yongchun Cao,
  • Yongchun Cao,
  • Yongchun Cao,
  • Zhengxing Man,
  • Zhengxing Man,
  • Zhengxing Man,
  • Rong Wang

DOI
https://doi.org/10.3389/fmolb.2022.956720
Journal volume & issue
Vol. 9

Abstract

Read online

To develop a deep image segmentation model that automatically identifies and delineates lesions of skeletal metastasis in bone scan images, facilitating clinical diagnosis of lung cancer–caused bone metastasis by nuclear medicine physicians. A semi-supervised segmentation model is proposed, comprising the feature extraction subtask and pixel classification subtask. During the feature extraction stage, cascaded layers which include the dilated residual convolution, inception connection, and feature aggregation learn the hierarchal representations of low-resolution bone scan images. During the pixel classification stage, each pixel is first classified into categories in a semi-supervised manner, and the boundary of pixels belonging to an individual lesion is then delineated using a closed curve. Experimental evaluation conducted on 2,280 augmented samples (112 original images) demonstrates that the proposed model performs well for automated segmentation of metastasis lesions, with a score of 0.692 for DSC if the model is trained using 37% of the labeled samples. The self-defined semi-supervised segmentation model can be utilized as an automated clinical tool to detect and delineate metastasis lesions in bone scan images, using only a few manually labeled image samples. Nuclear medicine physicians need only attend to those segmented lesions while ignoring the background when they diagnose bone metastasis using low-resolution images. More images of patients from multiple centers are typically needed to further improve the scalability and performance of the model via mitigating the impacts of variability in size, shape, and intensity of bone metastasis lesions.

Keywords